Magnesium, RNA and Australia's bioscience future
The 16th International Symposium on Applied Bioinorganic Chemistry (ISABC) was held in Ioannina, Greece, in June 2023. Organised by the University of Ioannina, it brought together researchers working where coordination chemistry, molecular biology and translational medicine meet. Its focus on applied bioinorganic chemistry made the biological roles of metals a timely subject for a global audience.
Magnesium has a central role in RNA folding and catalysis because it interacts with the phosphodiester backbone, bound water and nucleophilic groups. These interactions help RNA adopt compact tertiary structures and tune the chemical environment in which ribozymes operate. Coordination geometry, hydration and competition with monovalent ions all contribute, making magnesium a dynamic regulator rather than a passive counterion.
For applied research, this regulation offers routes to stabilise messenger RNA, design RNA aptamers, tune ribozyme activity and build catalytic systems for manufacturing and diagnostics. Therapeutic developers must define how much magnesium is required, which coordination states are active, and whether a formulation will behave consistently in cells, tissues or manufacturing buffers.
Australian researchers encounter these questions within a distinctive national ecosystem. Melbourne combines large-scale biopharmaceutical manufacturing with strong RNA and structural-biology groups, while Sydney, Brisbane and Adelaide host major molecular medicine programmes. National funding through the NHMRC and ARC, and a rigorous path for new medicines, connect discoveries with clinical and commercial evaluation.
Magnesium as an RNA folding partner
RNA folds through a combination of base pairing, hydrogen bonding, steric constraints and electrostatic interactions with the solvent. Magnesium ions bind phosphate oxygens and can also coordinate water, purine nitrogens and carbonyl groups. Such binding reduces the energetic penalty of bringing charged regions together and stabilises tertiary motifs, including stems, junctions and aptamer folds.
The effect is concentration-dependent and does not guarantee a single structure. Sufficient magnesium can favour compaction, while excessive ionic strength may promote alternative conformations or aggregation. Potassium, sodium, pH, temperature and chelating agents also alter the balance. Mechanistic studies should therefore report buffer composition, estimated free-ion concentrations and magnesium content alongside structural and kinetic measurements.
Catalytic chemistry inside complex folds
Ribozymes turn RNA itself into a catalyst, using folded architecture to position substrates, activate water and control leaving groups. Magnesium can participate directly through metal-ion catalysis or indirectly by organising the local hydration shell and supporting acid–base chemistry. In large ribosomal complexes, metal ions likewise help coordinate reactive centres and maintain the geometry required for peptide-bond formation.
The resulting mechanisms are dynamic rather than rigid snapshots. A metal-bound water molecule may exchange partners, and a catalytic fold may shift between pre- and post-cleavage states. This range of chemistry is reflected in the symposium scientific programme, which connected coordination chemistry, nucleic-acid folding and catalytic function within an applied setting.
From molecular insight to useful products
Applied bioinorganic chemistry asks how metal-dependent RNA behaviour can be controlled for a practical purpose. Engineered aptamers can use magnesium to sharpen recognition of small molecules, while designed ribozymes and RNA catalysts can be tuned through changes in sequence, solvent and ion concentration. In mRNA manufacturing, magnesium balance influences transcription, capping reactions and product integrity, making analytical controls essential.
The Australian market provides a useful industrial context for this work. CSL Behring’s Parkville manufacturing operations and the wider Melbourne biopharmaceutical supplier network illustrate the value of local expertise in biologics, quality systems and large-scale production. Sydney research groups contribute complementary strengths in RNA delivery, structural biology and cancer medicine, while national conferences support the cross-disciplinary exchange needed to move ideas between laboratories.
Commercialisation also depends on regulatory and quality expectations. The Therapeutic Goods Administration, based in Canberra, oversees the Australian pathway for medicines and vaccines, including candidates based on RNA technologies. Developers must show that identity, potency and stability remain controlled across manufacturing batches and storage conditions. Magnesium content and speciation can therefore become critical quality attributes rather than minor buffer details.
Building Australian research capacity
Australian laboratories can build capacity by combining national funding streams with international networks. NHMRC grants support health-focused mechanistic research, while ARC funding can connect chemical synthesis, biophysics and computational modelling. For early-career scientists, access to specialised facilities such as the Australian Synchrotron strengthens experimental design and makes international travel and collaboration more achievable.
Customs and biosecurity planning are equally practical for laboratories sharing constructs, samples or specialist reagents. The Australian Border Force and the BICON biosecurity system require relevant import conditions or permits to be checked before materials arrive. Good records should identify the organism, vector or nucleic-acid preparation, its intended use and its packaging, with lead time built into project scheduling.
The global health context extends beyond bench development. A practical example is preventing hepatitis B transmission, where timely screening, vaccine delivery and accessible public-health services shape lifelong outcomes. The lesson for RNA researchers is direct: molecular precision creates options, while reliable diagnostics, suitable delivery and public-health uptake determine whether those options produce meaningful benefit.
Presenting the work and widening collaboration
ISABC participation information covered young scientist travel awards, poster prizes, scholarships and the relevant application requirements. Zita Congress & Event Management served as the official symposium secretariat for registration, accommodation and abstract-related enquiries, providing one contact for practical arrangements and supporting collaboration across national boundaries.
Prospective presenters can use the abstract presentation guide to compare oral and poster formats and select the route that best fits the scientific question, the strength of the evidence and the audience. A focused oral presentation suits a mechanism with immediate translational implications, while a poster can support detailed exchange with specialist visitors and preserve the central findings in a visually immediate format.
Take the next step by sharing the symposium material with collaborators and contacting Zita Congress & Event Management, the official secretariat, about participation, abstract support, travel awards, poster prizes and scholarships. For future meetings, Australian delegates should begin with institutional approval, visa and travel-insurance checks, and confirm BICON requirements before carrying any biological material.